Platelets of healthy subjects and patients suffering from various disorders were assayed for their monoamine oxidase (MAO) activity and protein content. The latter tended to be lower with increasing platelet -count. A linear correlation with negative slope between count and protein content was found to exist in platelets obtained from schizophrenic, parkinsonian, and (specific development) dyslexia patients. MAO activities appeared to vary significantly with respect to age and sex. In schizophrenic patients, a significant depression of MAO activity occurred which was more marked in chronic than in acute cases. Even larger activity reductions were seen in platelets of insulin-dependent diabetics while the MAO was enhanced in male dyslexic boys. When MAO activity was assessed with different substrates and methods, the results correlated well with each other. Small, but consistent discrepancies, however, arose in the schizophrenia data when compared with the control values.
Since the time of the discovery of iproniazid as the first of what is now a long list of irreversible monoamine oxidase (MAO) inhibitors (Zeller et al. 1952a (Zeller et al. , 1952b (Zeller et al. , 1952c Zeller and Barsky 1952; Griesemer et al. 1953; Zeller, Barsky, and Berman 1955; Zeller 1958b) , our group has been interested in testing the effect of these agents in human subjects. At first, this was done indirectly by following the urinary excretion of products of MAO action, e.g., 5-hydroxyindoleacetic acid (5HIAA) (Zeller 1958a) or endogenous amines, e.g., tryptamine (Sjoerdsma et al. 1959) . However, it took about 10 days of iproniazid treatment before a significant drop in the urinary 5HIAA occurred. Thus, a more direct way of monitoring inhibitor action in human subjects was needed. This goal was reached when platelets were found to be an excellent source of MAO (Latt, Rippey, and Stacey 1968; Paasonen, Solatunturi, and Kivalo 1964; Zeller et al. 1968) . After having studied some properties of this enzyme, we proceeded to analyze the effect of inhibitor treatment on the platelet enzyme of volunteers. Oral administration of as little as .05 mg pargyline per kilogram body weight reduced platelet MAO activity by 84 percent within less than 1 hour (Cavanaugh 1969; Zeller, Babu, and Stanich 1969; Zeller et al. 1976) . We extended this work by assessing MAO activity in platelets of individuals of a wide range of ages and of both sexes. In several instances, significant differences in the enzyme activity were seen between various populations. Platelet MAO, therefore, appeared to reflect differences in amine metabolism in various physiological situations. On this basis, we investigated MAO in platelets isolated from the blood of patients suffering from Parkinson's disease, schizophrenia, specific development dyslexia (here referred to simply as dyslexia), and other disorders. In all cases we came upon deviations of MAO activities from those of age-and sex-matched controls. While in most published studies, determination of platelet proteins only served as the basis for MAO activity computations, we used platelet count and the protein method for this purpose. It seemed possible to us that not only the concentration of MAO but that of other proteins also may be influenced by a number of physiologic and pathologic processes. Actually, as shown below, platelet protein content appears to be a certain function of the platelet count.
Some Methodological Notes
Selection of Human Subjects. The schizophrenic patients were selected mainly from two populations: One was a relatively homogeneous group of male chronic schizophrenics, 30 to 53 years old, while the other group consisted of cases of acute and chronic schizophrenia which satisfied the Research Diagnostic Criteria and included males and females aged 16 to 54 years; patients of the second group went through a drug-free period of at least 3 weeks before blood samples were taken. The parkinsonian population was similar to that mentioned before (Zelleret al. 1976 ) and the corresponding dyslexic children and the age-and sex-matched controls will be described elsewhere.
1 Members of the student body and staff of Northwestern University Medical School volunteered as control subjects.
On the Isolation of Blood Platelets.
For this study, in general 20 ml of blood were drawn from each subject and the citrated specimens were centrifuged for 15 minutes at 190g. From the supernatant platelet-rich plasma (PRP), the platelets were separated by further centrifugation and washing of the pellet (Zeller et al. 1976) . By this procedure, a substantial amount of the platelets are left in the red cell layer. Recently it was demonstrated that large young platelets with high MAO activity are present in this portion (Friedhoff, Miller, and Karpatkin 1978) . Thus, the question arises whether and to what degree the platelet population used in our determinations is in any way representative of the total population. For this reason, we recently investigated the activity and specificity of MAO in platelets prepared from the same blood samples using the Corash method 2 and by our conventional procedure. With the former approach, up to 98 perc.ent of the platelets can be collected. For 16 samples, the average MAO activity was 21 percent (per mg pellet protein) and 23 percent (per platelet) higher in Corash-isolated platelets than in PRP platelets. This result, therefore, is in agreement with the above-mentioned observation that platelets left in the red cell layer after one centrifugation are supplied with a higher MAO activity. However, no differences in the specificity and inhibitor pattern of MAO present in the two platelet sets have been discovered so far. In this study, several monoamines, e.g., meta-iodobenzylamine, phenylethylamine, N-methylphenylethyla'mine, and octopamine were tested with and without clorgyline, deprenyl, and other inhibitors. 3 The range of these differences due to various isolation procedures is less than that seen among our populations. In addition, statisti- cal significance was demonstrated repeatedly for our material. These facts would indicate that the conventional procedure, with all its shortcomings, still yields consistent and representative results. From now on, however, it is to be replaced by methods which yield almost complete recovery of the platelets.
Measurement of Degradation Rates of Monoamines.
The degradation of tyramine and meta-iodobenzylamine (mlBA) was followed by the procedure of Snyder and Hendley (1968) and Tipton (1969) . In the measuring system of 3 ml, platelets isolated from 1.3 ml PRP were present and fluorescence readings were taken for 1 hour. We assayed the oxidation rate of para-methoxybenzylamine (pMBA) by assessing the increment of optical density at 286 nm which is due to the formation of the corresponding benzaldehyde with a molar extinction coefficient of 14,000 (Zeller et al. 1976 ). The experimental conditions were otherwise similar to those of the fluorometric procedure.
New Spectrophotofluorometric
Method for the Determination of Platelet MAO Activity. Although the enzyme activity data presented here (with the exception of those given in the section on platelet isolation) were obtained with the above listed methods, we want to mention that for some time now we have adopted one which is characterized by higher sensitivity and accuracy. It was adapted from the Kochli-von Wartburg (1978) procedure for assaying MAO to the measurement of this enzyme in platelets. 4 Herein, the oxidation of leuco-2',7'-dichlorofluorescein by the combined action of VOL 6, NO. 2, 1980 269 hydrogen peroxide and added peroxidase yields a product or products which display an optical density of 360,000 at 502 nm per mole of hydrogen peroxide. Two ml of blood and 5 to 10 minutes of incubation are sufficient for arriving at duplicate activity values.
Correlation Between Protein Content and Platelet Count. When platelet count and pellet protein were determined in a series of blood samples, the protein content of platelets increased linearly with the count. The computed linear correlation of the pellet protein values on platelet count, however, did not pass through the origin and instead showed a positive intercept on the ordinate. This apparently is due to a low protein content of platelets isolated from high count samples. The correlation of protein content of single platelets on platelet count produced a linear or near-linear relationship with a negative slope. In table 1 some of the pertinent data for various groups of healthy controls and patients are summarized, listing slopes and intercepts of the linear correlation. Without exception, all slopes are negative.
Studies on Platelet MAO
Multiple Substrates for MAO Determination. With all substrates; essentially the same ratios in activity with various groups are revealed (table 2). This conclusion is also borne out by the statistical analysis, which produces high correlation coefficients as computed for every substrate pair (table 2a) . High correlation coefficients were also reported by Murphy et al. (1977) for the pairs tyramine/tryptamine and benzylamine/tryptamine.
Sex and Age Differences in MAO
Activity. The data listed in tables 2 and 3 reveal a consistently higher MAO activity in females than in males and fully agree with our previously published results (Zeller et al. 1976 ). The present values for male controls are 73.5 ± 5.4 percent of those obtained for females. They are fairly close to some data presented in the literature, e.g., those of Takahashi and Karasawa (1975) 3) . In 1976, significant differences between the three major age groups had also been reported, viz. between children, adults, and subjects over 50 years old, with the activity reaching a minimum in the middle group. On separating the latter into two subclasses, the older group (MA) tended to exhibit lower values. Apparently, the age differences are related to sex differences: in general, androgens and, to a much lower degree, estrogens exert a depressing effect on MAO levels (Chordikian, 1967;  .0015
In the equation, y = ax + b, x is the number of platelets in 10 picoliters and y the protein content of one platelet, expressed in picograms. These units were chosen for the sake of convenience in order to arrive at simple figures for tabulation. Slope: a; intercept: b; correlation coefficient: r. probability characterizing thi degree of linearity of the correlation: p. .03 NS Schweppe, Zeller, and Higgins, 1951; Zeller et al. 1976) .
MAO Activity in Platelets of
Schizophrenic Patients. The enzyme activity values are significantly reduced in chronic schizophrenia as measured with all three substrates (table 2); they are also lower than those of acute cases of schizophrenia (table 4) . In general, the most convincing distinctions are observed with tyramine as the substrate. This is in agreement with the conclusions drawn by Demisch et al. (1977) from their own studies as well as from the work of Meltzer and Stahl (1974) . We observed reduction of MAO activity not only in schizophrenia, but also in dopa-treated parkinsonism and particularly in insulin-dependent diabetes. Increases in activity, on the other hand, are seen in dyslexic boys and in women suffering from glaucoma (Hodes, Shoch, and Zeller 1976) . In table 4 some of our pertinent data are presented (with a limitation to tyramine data for reasons just mentioned).
Qualitative or Quantitative Deviations in MAO of Schizophrenics?
The substantial depression of MAO activity in platelets of schizophrenics, as observed in many laboratories, could either be ascribed to the reduced concentration of MAO or to a defective enzyme produced at normal concentration. To gain some information regarding the second alternative, we determined platelet MAO activity with the help of three substrates and two methods for the reason that each substrate, according to its conformation and orientation, covers different parts of the active site when the transition state complex is formed. The experimental answer to the probing of the active site should, therefore, be different for each monoamine although not necessarily measurably different. Actually, it has been shown that the free energy of binding (AF°), as assessed by the interaction of various phenylethylamines and benzylamine with MAO types A and B, can vary by several kilocalories per mole (McEwen, Sasaki, and Jones 1969; Zeller and Arora 1979; Zeller et al. 1979) indicating some deep-seated differences in the substrate orientation on the active site. In addition, marked rate differences appeared when MAO interacted with the corresponding meta-and parasubstituted benzylamines (Zeller 1963) . Thus, we selected a phenylethylamine derivative, viz. tyramine, and a meta-and a parasubstituted benzylamine (mlBA and pMBA). All three amines are known to be excellent substrates of human platelet MAO (Zeller et al. 1976 ). In our preliminary report (Zeller et al. 1975) we had pointed out that the loss of MAO activity in platelets of schizophrenics was more marked with mlBA and tyramine as substrates than with pMBA. The same trend is also seen in our present data. This observation was thought to be indicative of a possible qualitative change in the patient's enzyme. There is another interpretation to be discussed: When aldehydes are formed from the monoamines by the action of MAO, they are liable to further oxidation. Takahashi and Karasawa (1975) have demonstrated that this step actually does take place in the degradation of serotonin in the presence of platelets. If that be the case, the observed rate values would be lower than the true ones when aldehyde production is the basis for quantitative measurements. Since the correlation coefficients, as mentioned above, are high when we compare the reaction rates obtained with several substrates, the errors obviously are not large in our case. Presently, we are engaged in an experimental analysis of this problem. Some interesting contributions to its ultimate solutions have been pro- vided by Berrettini, Vogel, and Clouse (1977) and by Belmaker, Rechem, and Ebstein (1978) Murphy and Wyatt (1972) stimulated research efforts aimed at determining whether this enzyme plays a role in the pathogenesis of some schizophrenias. It was, however, not the first attempt at linking these two entities because, almost 40 years ago, Birkhauser (1941) had reported a significant depression of MAO activity in the globus pallidus of schizophrenics. A second step was taken in 1958 when some schizophrenic patients were treated with the MAO inhibitor iproniazid and with the amino acid L-tryptophan, a precursor of serotonin (5HT) (Lauer et al. 1958; Zeller 1958a ). This was done because it had been suggested that some mental disorders could arise from a 5HT deficiency in the brain. We tried to elevate cerebral 5HT levels in schizophrenic patients by inhibiting MAO and by enhancing the production rate of this amine through the administration of relatively large amounts of tryptophan. We already knew that in vivo MAO could be almost completely inactivated in animal brains by iproniazid (Zeller and Barsky 1952) . Since this drug had been used in the treatment of patients suffering from tuberculosis and angina pectoris, we could take advantage of that experience to select a safe and proper dosage. Chronic schizophrenic patients received iproniazid and tryptophan for 4 weeks. After 11 days the excretion of 5HIAA dropped significantly and, simultaneously, marked behavioral changes occurred. The latter were characterized by an elevation of energy levels, increased motor activity, and a greater display of interest in the external environment by the patients. These transformations were dramatic because all individuals had been utterly withdrawn, mute, and lethargic before treatment. The stage of activation, however, was followed by increasing anxiety culminating in a phase simulating (or being) an acute attack of schizophrenia. For various reasons we were not able to continue our pilot study and to fight our way out of the beachhead. Fortunately, a little later, this line of investigation was taken up by the National Institute of Mental Health (Pollin, Cardon, and Kety 1961) and then by several other laboratories. In these extensive investigations not only a stronger basis for the iproniazid + tryptophan effects was provided but also methionine was found to produce what might be described as a "biochemically induced acute flare-up of a chronic schizophrenic process" (Pollin, Cardon, and Kety 1961, p. 105) .
This short summary of some work done in the past suggests that certain relationships between MAO and some forms of schizophrenia really may exist. But many more experimental and clinical studies are needed before all information can be integrated and before a model can be built of the exact role of monoamine oxidases, if any, in the pathogenesis of schizophrenia.
It has been a long way for one of the present authors from the time he had proposed the present name of MAO (Zeller et al. 1939 ) to a highly informative conference exclusively dedicated to the exploration of this one enzyme in one cell of one group of patients.
